Canakinumab

canakinumab · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

52 regulatory and trial events tracked for Canakinumab, covering 2009-02-17 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial [Phase 2]